Pelago

Pelago, a digital clinic partner to U.S. businesses and health plans for substance use management, announced Tuesday the addition of cannabis to its specialized substance use disorder (SUD) treatments. The new program, which will be fully implemented by Q3 2024, expands the New York-headquartered...

Groupon (NASDAQ: GRPN) on Monday announced that its product chief Jeffrey Holden is leaving the company to pursue opportunities at a non-competing company. Holden joined Groupon after his startup company, Pelago, was acquired in 2011. Holden's prior experience includes nearly 10 years at...